Glooma (private company)

See something wrong or missing? Let us know
Offices:Lisbon
Business model:B2B

Glooma is a health startup in Portugal focused on the early prevention of breast cancer

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 362.97k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Glooma

Name Criteria
Denmark Henlez ApS
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom GeneHub
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland FluoSphera
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: < 1M USD
Sweden MedVasc
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Mirna
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Ability Pharma
55%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
United Kingdom Beckley Psytech
55%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
Norway Curida
55%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
Denmark Octarine Bio
55%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
France Pharmedigroup
55%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top